NameBetahistine tablets 24mg in box No. 10×3 The main active ingredient betahistine dihydrochloride Release form Tablets Dosage 24mg Indications for use Symptomatic treatment of recurrent dizziness with or without cochlear symptoms. Dosage and administration Inside, during meals, the tablets are swallowed without chewing, with a glass of water. Dosage 8 mg The usual dosage is 1 – 2 tablets 3 times a day, but not more than 6 tablets, i.e. 48 mg betahistine per day. Dosage 16 mg The usual dosage is ½ – 1 tablet 3 times a day. Dosage 24 mg This dosage form is intended for use in patients requiring a daily dose of 48 mg betahistine. In other cases, lower doses should be used. The usual dosage is 1 tablet 2 times a day. Children and adolescents Betahistine is not recommended for use in children and adolescents under 18 years of age due to insufficient data on efficacy and safety. Elderly patients Betahistine should be used with caution in elderly patients because the available safety data are limited. Renal insufficiency There are no data on the use in patients with renal insufficiency. Hepatic insufficiency There are no data on the use in patients with hepatic insufficiency. Duration of treatment The recommended duration of treatment is 2 to 3 months, treatment may be extended depending on the course of the disease. Treatment is possible with intermittent or continuous courses. Contraindications Hypersensitivity to any of the components of the drug. Active form of peptic ulcer. Pheochromocytoma. One tablet contains – active ingredient: betahistine dihydrochloride – 8 mg, 16 mg or 24 mg; excipients: mannitol, citric acid monohydrate, anhydrous colloidal silicon dioxide, croscarmellose sodium, talc, microcrystalline cellulose. Buy Betahistine tablets 24mg No. 10×3 Price for Betahistine tablets 24mg No. 10×3
INN | BETAGISTINE |
---|---|
The code | 102 880 |
Barcode | 4 810 201 013 190 |
Dosage | 24mg |
Active substance | Betahistine |
Manufacturer | Borisovsky ZMP, Belarus |
Indications Applications | Symptomatic treatment of recurrent vertigo with or without cochlear symptoms. |
Contraindications | Hypersensitivity to any of the components of the drug. Active form of peptic ulcer. Pheochromocytoma. |
Use during pregnancy and lactation | unknown |
Application Gender | Any |
Release Form | tablets |
Main Active Substances | betahistine dihydrochloride |
Composition Means | one tablet contains – active substance: betahistine dihydrochloride – 8 mg, 16 mg or 24 mg; excipients: mannitol, citric acid monohydrate, anhydrous colloidal silicon dioxide, croscarmellose sodium, talc, microcrystalline cellulose. |
Be the first to review “Betahistine tablets 24mg №10×3” Cancel reply
Related products
Improvement of cerebral circulation
$14.00
Improvement of cerebral circulation
$20.00
Reviews
There are no reviews yet.